Skip to content
  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
Daily News India

Daily News India

Just another WordPress site

  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
  • Toggle search form
  • Coach Unveils Iconic New York Style at Grand Opening in Palladium Ahmedabad Lifestyle
  • 29th Edition Lions Gold Awards to Celebrate the Selfless Spirit of the “INDIAN ARMY” Business
  • The film “Mystery A Truth” by Raja Gangopadhyay released in Mumbai Entertainment
  • Unveiling the Charm of Bonzo Peter’s Shop: A Tale of Love and Companionship Lifestyle
  • BlueRose Publishers Announces the Release of “Universal Money Codes Book” by Dr. Waikhom Roshni Devi Business
  • Hafele’s ASKO and Falmec Luxury Appliances Business
  • Top-rated Affordable Housing Projects in Greater Noida West by Residents Business
  • What’s So Unique About Online MBA? Uncover How It Boosts Your Career Education

Akums Drugs receives EU GMP approval for two Haridwar-based manufacturing plants

Posted on July 11, 2022 By

Akums Drugs & Pharmaceuticals Ltd. has recently received European Union GMP approval for two of their manufacturing units in Haridwar.

New Delhi (India), July 11: Akums Drugs & Pharmaceuticals Ltd., the leading contract manufacturing pharmaceutical company in India, has recently acquired the stringent European Union (EU) GMP  approval for two of their manufacturing units in Haridwar. Following this prestigious nod, the gateway for several new opportunities in the European and other stringent regulatory markets is open to Akums Drugs. This move is another assent to Akums’ “Quality First” approach to work, which has now been endorsed by the EU -GMP beside all top-notch Indian and multinational pharmaceutical companies, who are already Akums’ long-standing partners.

Akums has received EU GMP approval for its two manufacturing plants. One plant manufactures solid oral dosage forms such as tablets, hard gelatin capsules, powders in sachets, etc. belonging to the general category, and Another plant manufactures large volume parenteral and small volume parenterals lines, including vials, ampoules, eyedrops, FFS  as well as for dry powder injections in the penicillin line.

Founder, Promoter and Director, Akums Drugs & Pharmaceuticals, Shri Sandeep Jain, says, “We are happy to announce that Akums Drugs has received EU GMP approval for two of our Haridwar-based manufacturing facilities, thus paving the path for new opportunities from the entire European Union as well as many other regulatory markets. We are already the largest Indian contract manufacturing company, manufacturing > 12% of country’s domestic supply, but what makes us happiest is being recognised for our “Quality First” approach. While we have been endorsed for this quality by our partners, who are also leading Indian and multinational pharmaceutical companies, the latest one from the EU GMP is very widely recognised & accepted. Congratulations to the entire team, and I hope this is the beginning of numerous possibilities for us.”

Founder, Promoter and Director Akums Drugs & Pharmaceuticals, Shri Sanjeev Jain, says, “Akums is already exporting to over 50 countries worldwide. With the esteemed EU GMP nod, we have now gained access to the most stringent global pharmaceutical markets besides the USA. These include the entire European Union, other markets like South Africa, Canada, Malaysia, Indonesia, Thailand, Australia/New Zealand and most middle-eastern countries. Since the EU GMP is their gold standard, we are welcome to cater to the pharmaceutical demands of all these geographies. With a large R&D infrastructure already in place, we are well equipped with a good basket of Products in our pipeline to expand our presence in these regulated markets. While we are extremely proud and excited to expand our presence in these markets, the Indian domestic market has always been our pride & passion and will continue to be so. The trust our partners have in us, and our Quality is paramount for us. ”

Akums Drugs & Pharmaceuticals Ltd. is India’s largest contract manufacturing pharmaceutical company, manufacturing more than 12% of India’s consumption. The organisation deals in manufacturing and exporting formulations in a broad spectrum of dosage forms & therapeutic segments. The company currently supplies to almost all Indian and multinational pharmaceutical companies across the globe and is the 67th largest employer in the country. The ten state-of-the-art facilities are dedicated to oral solid dosage forms (with separate units for beta lactum and non-beta lactum formulations), Oral liquid dosage forms, Sterile dosage forms (injectable, eye, ear & nasal), hormonal (oral and injectable), ointments & cosmetics, personal care,  Ayurvedic, food supplements & nutraceuticals and animal health care.

In a few years, the organisation has become the icon of the Indian pharmaceutical manufacturing industry and currently manufactures more than 12% of the country’s total medicinal requirements. With creme-de-la-creme of dedicated pharmaceutical personnel and standardised practices, Akums has been successful in attaining national and international accreditations and building trust-based on efficacy, safety & quality. The organisation is certified with WHO-GMP, ISO 9001:2015, ISO 14001:2015 certificates and various international accreditations, like; ANVISA, Brazil, NAFDAC, Nigeria, FDB, Ghana, PMPB, Malawi, amongst others and exports to 53 countries across the world.

If you have any objection to this press release content, kindly contact pr.error.rectification@gmail.com to notify us. We will respond and rectify the situation in the next 24 hours.

Business Tags:Business

Post navigation

Previous Post: KPar Smart Products Announces 1 year report on Smart Cities
Next Post: La Excellence announced the launch of its Batch-2 for students aspiring to enter into the Civil Services in Telangana on July 11

Related Posts

  • Home Investment Magic: Where Cash Comes Back Like a Boomerang! Business
  • Luxury Time Limited IPO To Open On 04th December, Sets Price Band at Rs 78 to Rs 82 Per Share Business
  • 2nd Inter FoodTech Expo To Be Held From 7 – 9 June 2023 At Mumbai India Concurrently With ‘Snack & BakeTec’ And ‘Pac MechEx’ Business
  • With Cloud Odyssey, Suresh Goli Realizes His Passion For Salesforce and MuleSoft Solutions Business
  • Sarvatra Group forays into hospitality business with premium resort near Ratanpur Business
  • Hewa’s International Home Textile Summit in Varanasi sparks global collaboration and innovation Business

Recent Posts

  • India Takes Centre Stage at the 79th Festival de Cannes
  • Imperial College London announces STEMathon 3.0, calling India’s most ambitious students to solve real world challenges
  • In the Age of AI, Telangana’s CogniCHAMP Is Measuring What Machines Cannot
  • Tasveer Hosts the Only Official South Asian Panel on the Main Stage of Cannes Du Marche
  • Flipkart Elevates Ankit Agarwal to Vice President, Business Finance

Recent Comments

  • Unknown on Participants Reap Rewards in Wellman’s 8-Week Digital Campaign: IPL Tickets, Autographed Virat Kohli Merchandise, and More!
  • A Captivating Discussion and Launch of Sunil Gadhoke’s Book on the Tiger Lifestyle
  • The New Mrs. India- She Is India Queens Have Claimed Their Crown! Lifestyle
  • S. R. Luthra Institute of Management Receives SGCCI Golden Jubilee Award for 2023-24 Education
  • Award-Winning Author Ajay Vyshampayan Releases Emotional New Novel About Indian Air Force Heroes Lifestyle
  • Team India Shines at Kudo Japanese mixed combat sport World Cup in Bulgaria Sports
  • Higher education must prepare students for the future of work, says Dr. Ajeenkya DY Patil Press Release
  • Appinop Is Revolutionizing The Cryptoexchange Industry By Bringing New Technology To The Turf Business
  • How the Best SMM Panel Is Changing Social Media Growth in 2026 Business

Copyright © 2026 Daily News India.

Powered by PressBook News WordPress theme